How Mechanical Pressure Influences Epigenetic Changes in Cancer Cells

New insights reveal how mechanical confinement within the tumor environment induces epigenetic changes in cancer cells, promoting invasion and drug resistance, highlighting the role of physical forces in tumor progression.
Recent research reveals that physical forces within the tumor microenvironment can significantly influence cancer cell behavior by triggering epigenetic modifications. A study led by Richard White and Miranda Hunter at Ludwig Oxford and the Memorial Sloan Kettering Cancer Center, published in Nature, demonstrates that cellular confinement—mechanical pressure exerted by surrounding tissues—acts as a catalyst for epigenetic reprogramming in melanoma cells. When tumor cells are tightly confined, they undergo structural and functional transformations, shifting from a proliferative state to an invasive phenotype. A key player in this process is HMGB2, a DNA-bending protein that responds to mechanical stress by binding to chromatin and modifying gene packaging. This exposes genomic regions linked to invasiveness, allowing cancer cells to become more migratory and resistant to treatments. Additionally, melanoma cells respond to external pressure by remodeling their internal skeleton, forming a protective cage around the nucleus through the LINC complex, which safeguards against nuclear rupture and DNA damage under stress. These mechanical cues prompt cytoskeletal reorganization, further supporting the invasive transformation. The findings emphasize how physical forces within the tumor microenvironment are potent drivers of epigenetic changes and phenotypic plasticity, contributing to treatment resistance. Understanding these mechanotransduction pathways opens new avenues for therapies aimed at preventing the invasive and drug-resistant states of cancer cells, addressing one of the major challenges in oncology.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Common Lung Cancer Symptom Medication May Reduce Effectiveness of Immunotherapy
New research shows that corticosteroids used to manage lung cancer symptoms may reduce the effectiveness of immunotherapy treatments. Learn how steroid use impacts immune response and patient outcomes.
Repurposing Asthma Medication for Treating Rare Neurological Disorder ADCY5-Related Dyskinesia
Research indicates that the asthma medication theophylline may help manage symptoms of ADCY5-related dyskinesia, a rare neurological disorder, offering hope for improved patient quality of life.
Innovative Digital Twin Technology Enhances Artificial Pancreas for Better Diabetes Management
A new digital twin technology integrated into artificial pancreas systems significantly improves blood sugar control for people with type 1 diabetes by enabling personalized, adaptive management.
Advancements in AI Enhance Precision and Speed in Lung Tumor Monitoring
Cutting-edge AI software is revolutionizing lung tumor detection by offering faster, more accurate comparison of CT scans—improving diagnosis and patient care.